蒋亚文

中山大学公共卫生学院（深圳） 副教授



电子邮件
jiangyw26@mail.sysu.edu.cn



硕士生导师，中山大学****引进人才研究方向卫生与药物经济学、医疗保险、真实世界证据、应用计量经济学及药物流行病学
工作经历2019/04至今??? 中山大学公共卫生学院（深圳），副教授
2016/03-2019/04?? 美国安进公司 (Amgen Inc.) ，全球卫生经济学经理
2012/05-2016/03?? 南加州大学Schaeffer卫生政策与经济研究中心，研究助理
讲授课程本科：卫生经济学基础、卫生事业管理等
研究生：人口老龄化与健康政策
教育经历2012/08-2016/03?? 南加州大学，药物与卫生经济系，哲学博士
2010/08-2012/05?? 南加州大学，药物经济与政策系，理学硕士
2006/09-2010/07?? 暨南大学，药学、金融，理学学士及经济学学士
?
主要承担课题及人才项目1.国家自然科学基金，青年基金项目，基于动态微观模拟的老年人群失能状况与疾病负担推演及相关政策评估，2021.01-2023.12，24万元，在研，主持
?
2.广东省基础与应用基础研究基金，区域联合基金青年基金项目，基于个体模拟的深圳市重点人群流感疫苗接种策略的卫生经济评价，2020.01-2022.12，10万元，在研，主持
发表论文2019年5月至2021年1月
25. Jiang, Y.*?& Ni, W. Impact of supplementary private health insurance on hospitalization and physical examination in China.?China Economic Review. (2020). doi: 10.1016/j.chieco.2020.101514
24. Jiang, Y.^#*, Ye, Z^#, Chen, D, & Shu, Y*. Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study. Emerging Microbes & Infections. (2020). doi: 10.1080/**.2020.**
23. Jiang, Y.*?& Ni, W. Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes. BMC Medical Research Methodology. (2020). doi: 10.1186/s12874-020-01124-6
22. Jiang, Y.*,?Jiang, S. & Ni, W. The burden of cardiovascular diseases associated with fine particulate matter in Beijing, China: an economic modelling study. BMJ Global Health. (2020). doi: 10.1136/bmjgh-2020-003160
21. Jiang, Y.*,?Chen, D. Cai, D., Yi, Y. & Jiang, S. Effectiveness of remdesivir for the treatment of hospitalized Covid-19 persons: a network meta-analysis. Journal of Medical Virology. (2020). doi: 10.1002/jmv.26443
20. Jiang, S., Chen, Z., Wu, J., Zang, X., & Jiang, Y. *?Addressing Methodological and Ethical Issues in Practicing Health Economic Evaluation in China. Journal of Global Health. (2020). doi: 10.7189/jogh.10.020322
19. Jiang, Y.*,?Cai, D., Chen, D. & Jiang, S. The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from the epidemic in Wuhan, China.?BMJ Global Health. (2020) doi: 10.1136/bmjgh-2020-002690
18. Jiang, Y.*?& Ni, W. Association Between Supplemental Private Health Insurance and Burden of Out-of-Pocket Healthcare Expenditure in China: A Novel Approach to Estimate Two-Part Model with Random Effects Using Panel Data. Risk Management & Healthcare Policy. (2020) 13:323-334.?doi: 10.2147/RMHP.S223045
17. Papaioannou, A., Adachi, J. D., Berger, C., Jiang, Y.*, Barron, R., McGinley, J. S., ... & Ioannidis, G. Testing a theoretical model of imminent fracture risk in elderly women: an observational cohort analysis of the Canadian Multicentre Osteoporosis Study. Osteoporosis International.?(2020) doi: 10.1007/s00198-020-05330-2
16. Jiang, Y.*?& Ni, W. Risk selection into supplemental private health insurance in China. Health Economics Review. (2019) 9:36.
15. Jiang, Y.,?Ni, W. & Wu, J.* Cost-effectiveness and Value-based Prices of the 9-valent Human Papillomavirus Vaccine for the Prevention of Cervical Cancer in China: An Economic Modelling Analysis. BMJ Open. (2019) doi: 10.1136/bmjopen-2019-031186
?
2019年5月以前
14. Jiang, Y.*?& Ni, W. Economic Evaluation of the 2016 Chinese Guideline and Alternative Risk Thresholds of Initiating Statin Therapy for the Management of Atherosclerotic Cardiovascular Disease. PharmacoEconomics. (2019) 37: 943–952.?doi:?10.1007/s40273-019-00791-8
13. Jiang, Y.*, Ni, W. Factors Related to the Comparative Effectiveness of Clozapine in Patients with Schizophrenia. Journal of Comparative Effectiveness Research. (2019) 8:3, 179-185. doi: 10.2217/cer-2018-0096
12. Jiang, Y.*, Ni, W. Estimates of Age-specific Diabetes Incidence among Men and Women in China Using Secondary Data Analysis. Diabetic Medicine. (2019) 36: 388–389.?doi: 10.1111/dme.13821
11. Jiang, Y.*, McCombs, J. S., & Park, S. H. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics. CNS drugs 31.4 (2017): 319-326. doi: 10.1007/s40263-017-0421-4
10. Ni, W. & Jiang, Y.*?Evaluation on the Cost-effective Threshold of Osteoporosis Treatment on Elderly Women in China Using Discrete Event Simulation Model. Osteoporosis International. 2017 Feb;28(2):529-538.?doi: 10.1007/s00198-016-3751-z.
9. Jiang, Y.*?& Ni, W. Expected Lifetime Numbers, Risks, and Burden of Osteoporotic Fractures for 50-Year Old Chinese Women— a Discrete Event Simulation Incorporating FRAX. Journal of Bone and Mineral Metabolism. 2016 Nov;34(6):714-722. doi: 10.1007/s00774-015-0724-9.
8. Jiang, Y.*?& Ni, W. Healthcare Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment. Journal of Managed Care Pharmacy. 2015 Sep;21(9):780-92. doi: 10.18553/jmcp.2015.21.9.780.
7. Jiang, Y.*?& Ni, W. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization. Pharmacotherapy. 35.9 (2015): 813-822. doi: 10.1002/phar.1634.
6. Jiang, Y.*, Ni, W., McGinnis, J. Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA. Clin Drug Investig:?34.7 (2014): 491-499. doi:10.1007/s40261-014-0202-5.
5. Jiang, Y.*?& McCombs, J. Improving Model Specifications When Estimating Treatment Effects across Alternative Medical Interventions. Open Journal of Statistics, 4.10 (2014): 857. doi: 10.4236/ojs.2014.410081.
4. Trief, P.*, Jiang, Y., Beck, R., Huckfeldt, P., Knight, T., Miller, K., Weinstock, R. Adults with Type 1 Diabetes: Partner Relationships and Outcomes. Journal of Health Psychology. 22.4 (2017): 446-456. doi:10.1177/**05654.
3. Thomas, K.*, Jiang, Y., McCombs, J. Clozapine Revisited: Impact of Clozapine versus Olanzapine on Health Care Use by Medicaid Schizophrenia Patients. Annals of Clinical Psychiatry 27.2 (2015): 90-99.
2. He, X., Wu, J.*, Jiang, Y., Liu, L., Ye, W., Xue, H., & Montgomery, W. Health Care Resource Utilization and Direct Medical Costs for Patients with Schizophrenia Initiating Treatment with Atypical Versus Typical Antipsychotics in Tianjin, China. BMC Health Services Research, 15.1 (2015): 149. doi: 10.1186/s12913-015-0819-y.
1. O'Hanlon, C., Parthan, A., Kruse, M., Cartier, S., Stollenwerk. B., Jiang, Y., Caloyeras, J., Crittenden, B., Barron, R.* A Model for Assessing the Clinical and Economic Benefits of Bone-Forming Osteoporosis Agents in Reducing Fractures in Post-Menopausal Women at High, Near-Term Risk of Fragility Fracture. Clinical Therapeutics 39.7 (2017): 1276-1290.?doi: 10.1016/j.clinthera.2017.05.348
?
兼职情况?
1.中国研究型医院学会药物经济学专业委员会青年委员
2.广东省预防医学会社会医学与卫生事业管理专业委员会委员
3.深圳市乳腺癌防治联盟卫生经济学组副组长。
?
招生信息? ?? 招收硕士生2人左右/年，并接收本科生进行科研培训。欢迎有志于卫生与药物经济、真实世界数据、决策分析等领域的来自流行病学、经济学、统计学、数学、管理学等相关专业的同学加入我们。